Moleculin Biotech
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $406 | $406 |
Gross Profit | -31 | -32 | 371 | |
EBITDA | -7,104 | -6,154 | -6,645 | -8,884 |
EBIT | -7,135 | -6,185 | -6,677 | -8,919 |
Net Income | -10,592 | -4,319 | -4,970 | -10,269 |
Net Change In Cash | 0 | 0 | 406 | 406 |
Free Cash Flow | -6,113 | -5,962 | -6,717 | -5,488 |
Cash | 9,405 | 10,845 | 16,824 | 23,550 |
Basic Shares | 3,714 | 2,543 | 2,466 | 2,003 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -127 | -222 | -260 | -285 |
EBITDA | -29,504 | -30,510 | -22,804 | -19,542 |
EBIT | -29,631 | -30,732 | -23,064 | -19,827 |
Net Income | -29,769 | -27,410 | -8,860 | -14,996 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 4,404 | |||
Free Cash Flow | -24,225 | -27,706 | -18,970 | -18,147 |
Cash | 23,550 | 43,145 | 70,903 | 15,173 |
Basic Shares | 1,975 | 1,906 | 1,791 | 656 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$2.85 |
2024-06-30 | -$1.70 |
2024-03-31 | -$2.02 |
2023-12-31 | -$5.02 |
